Tag Archives: Special Access Scheme

Cann Group reach cannabis distribution agreement with Symbion

Cann Group Limited (Cann) is launching a range of imported medicinal cannabis products to be distributed to approved Special Access Scheme (SAS) patients by Symbion Pty Ltd. Cann’s agreement with Symbion, suppliers of healthcare services and products to more than 4000 retail pharmacies and 1300 hospitals throughout Australia, will ensure …

Read More »

Medlab to distribute cannabis meds abroad

Australian life sciences company Medlab Clinical is preparing for international distribution of its cannabis-based medicine, NanaBis. After signing a heads of agreement with fourth largest Canadian generic pharmaceutical company, Pharmascience, in March this year, Medlab Clinical has now signed an HoA with Mega Lifesciences Public Company Ltd for the distribution …

Read More »